Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGCP Infrastructure Investments Regulatory News (GCP)

Share Price Information for GCP Infrastructure Investments (GCP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 77.20
Bid: 77.00
Ask: 77.10
Change: 0.00 (0.00%)
Spread: 0.10 (0.13%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 77.20
GCP Live PriceLast checked at -
GCP Infrastructure Investments is an Investment Trust

To provide shareholders with regular, sustainable, long-term dividend income and to preserve the capital value of its investments over the long term by generating exposure to infrastructure debt and/or similar assets.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Comment on Budget Statement

9 Jul 2015 14:16

RNS Number : 6481S
GCP Infrastructure Investments Ltd
09 July 2015
 



 

 

9 July 2015

 

GCP Infrastructure Investments Limited

("the Company")

Comment on Budget Statement

 

The Board of Directors of the Company has noted the Chancellor's statements in yesterday's Budget relating to the removal of the Climate Change Levy exemption for certain renewable energy projects from 1 August 2015.

Gravis Capital Partners LLP, the investment adviser to the Company, has conducted a preliminary review of the potential impact of these statements on the assets of the Company. It is the view of the Board, as advised by the investment adviser, that a minority (by value) of the projects against which the Company has provided debt will see a modest reduction in the forecast net cashflows available to service such debt during the period to 2022.

However, it is the opinion of the investment adviser that these reductions will not have a material impact on the ability of the projects to service such debt. As a result, it is the view of the Board, as advised by the investment adviser, that the cashflows expected to arise from the investments held by the Company will be wholly unaffected by the removal of the Climate Change Levy exemption.

Ian Reeves, the chairman of the Company, commented "The Company offers shareholders exposure to subordinated PFI debt and related assets including renewable energy. Its focus on investing in debt instruments ensures that the Company benefits from an element of protection whereby equity holders in investee projects suffer the first loss arising from any reduction in projects' free cash flows. In light of yesterday's announcement of a reduction in the level of public sector support for certain renewable energy projects, it is pleasing to see that the fundamentally conservative approach of the Company in providing debt to such projects leaves the Company essentially unaffected by that announcement".

 

Contact details:

 

Gravis Capital Partners LLP

 

Stephen Ellis

+44 (0)20 7518 1495

Rollo Wright

+44 (0)20 7518 1493

 Stifel Nicolaus Europe Limited

 

Neil Winward

+44 (0)20 7710 7600

Mark Bloomfield

 

Tunga Chigovanyika

 

Cenkos Securities

 

Dion Di Miceli

+44 (0)20 7397 1921

Tom Scrivens

+44 (0)20 7397 1915

Buchanan

 

Charles Ryland

+44 (0)20 7466 5000

Victoria Watkins

 

 

Notes to Editors

The Company

The Company is a closed-ended London Stock Exchange-listed investment company that seeks to generate returns from senior and subordinated infrastructure debt and related and/or similar assets. The Company is advised by Gravis Capital Partners LLP.

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLLFLVDEIAIIE
Date   Source Headline
28th Apr 20236:11 pmRNSTotal Voting Rights
28th Apr 20235:00 pmRNSTransaction in Own Shares
28th Apr 20234:01 pmRNSChange of Registered Office
27th Apr 20237:00 amRNSNet Asset Value(s)
27th Apr 20237:00 amRNSDividend Declaration
19th Apr 20235:27 pmRNSTransaction in Own Shares
18th Apr 20235:49 pmRNSTransaction in Own Shares
5th Apr 20235:31 pmRNSTransaction in Own Shares
31st Mar 20235:18 pmRNSTotal Voting Rights
30th Mar 20237:00 amRNSDirector Declaration
29th Mar 20235:24 pmRNSTransaction in Own Shares
28th Mar 20234:53 pmRNSTransaction in Own Shares
27th Mar 20234:34 pmRNSTransaction in Own Shares
15th Mar 20235:15 pmRNSTransaction in Own Shares
14th Mar 20235:22 pmRNSTransaction in Own Shares
14th Mar 20237:00 amRNSShare Buyback Programme Initiated
23rd Feb 20237:00 amRNSDirector/PDMR Shareholding
20th Feb 202312:27 pmRNSHolding(s) in Company
15th Feb 202311:42 amRNSResult of AGM
13th Feb 20233:25 pmRNSHolding(s) in Company
7th Feb 20234:52 pmRNSUpdate research from QuotedData
2nd Feb 202310:34 amRNSInvestor Report at 31 December 2022
31st Jan 20233:52 pmRNSDirector/PDMR Shareholding
27th Jan 20237:00 amRNSNet Asset Value(s)
27th Jan 20237:00 amRNSDividend Declaration
12th Jan 20239:55 amRNSNotice of net asset value announcements
11th Jan 20239:15 amRNSDirector Declaration
9th Jan 20239:15 amRNSNotice of AGM
15th Dec 20227:00 amRNSAnnual report and financial statements
28th Oct 20227:00 amRNSDirectorate Change
28th Oct 20227:00 amRNSInvestor Report at 30 September 2022
26th Oct 20227:00 amRNSDividend Declaration
20th Oct 20227:00 amRNSNet Asset Value(s)
30th Sep 202211:13 amRNSResult of EGM
30th Sep 20227:00 amRNSTotal Voting Rights
13th Sep 20225:21 pmRNSNotice of EGM
6th Sep 20229:18 amRNSAdditional Listing and Total Voting Rights
25th Aug 20229:30 amRNSAdditional Listing
11th Aug 20227:00 amRNSScrip Share Reference Price
29th Jul 20227:00 amRNSInvestor Report at 30 June 2022
27th Jul 202212:37 pmRNSResearch from QuotedData
26th Jul 202210:59 amRNSDividend Declaration & Scrip Dividend Alternative
14th Jul 20227:00 amRNSNet Asset Value(s)
30th Jun 20227:00 amRNSTotal Voting Rights
21st Jun 20227:05 amRNSDirectorate Change
21st Jun 20227:00 amRNSHalf-yearly report and financial statements 2022
7th Jun 20229:43 amRNSAdditional Listing and Total Voting Rights
26th May 20229:17 amRNSAdditional Listing
20th May 20223:56 pmRNSHolding(s) in Company
12th May 20227:00 amRNSScrip Share Reference Price

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.